COPANI, Agata Graziella
 Distribuzione geografica
Continente #
NA - Nord America 7.892
AS - Asia 4.240
EU - Europa 3.587
SA - Sud America 702
AF - Africa 346
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 16.784
Nazione #
US - Stati Uniti d'America 7.579
SG - Singapore 2.116
RU - Federazione Russa 1.197
CN - Cina 1.153
IE - Irlanda 647
BR - Brasile 595
UA - Ucraina 582
IT - Italia 394
VN - Vietnam 278
CA - Canada 266
HK - Hong Kong 225
FR - Francia 185
KR - Corea 149
CI - Costa d'Avorio 145
DE - Germania 135
SE - Svezia 113
GB - Regno Unito 103
NG - Nigeria 89
IN - India 80
AR - Argentina 45
SN - Senegal 36
BD - Bangladesh 33
PL - Polonia 33
FI - Finlandia 29
CH - Svizzera 28
ZA - Sudafrica 27
MX - Messico 25
PK - Pakistan 25
ES - Italia 23
UZ - Uzbekistan 23
NL - Olanda 22
TR - Turchia 22
IQ - Iraq 20
AT - Austria 19
IR - Iran 19
JP - Giappone 17
CZ - Repubblica Ceca 13
BE - Belgio 12
CO - Colombia 12
GR - Grecia 10
KE - Kenya 10
SA - Arabia Saudita 10
BJ - Benin 9
EC - Ecuador 9
LB - Libano 9
UY - Uruguay 9
VE - Venezuela 9
AU - Australia 8
ID - Indonesia 8
PY - Paraguay 8
CL - Cile 7
CR - Costa Rica 7
EG - Egitto 7
EU - Europa 7
MA - Marocco 7
NP - Nepal 7
PH - Filippine 7
AZ - Azerbaigian 6
BG - Bulgaria 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
HU - Ungheria 5
IL - Israele 5
JM - Giamaica 5
KZ - Kazakistan 5
RO - Romania 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
JO - Giordania 4
TN - Tunisia 4
AL - Albania 3
BY - Bielorussia 3
LT - Lituania 3
MY - Malesia 3
PT - Portogallo 3
AO - Angola 2
BB - Barbados 2
BO - Bolivia 2
DK - Danimarca 2
HR - Croazia 2
NO - Norvegia 2
OM - Oman 2
PR - Porto Rico 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
BA - Bosnia-Erzegovina 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MG - Madagascar 1
MN - Mongolia 1
MU - Mauritius 1
Totale 16.776
Città #
Dallas 1.347
Singapore 1.183
Santa Clara 870
Jacksonville 661
Chandler 648
Dublin 646
San Jose 469
Moscow 456
Ashburn 406
Boardman 303
Chicago 255
Nanjing 202
Toronto 190
Cambridge 185
Hefei 183
Andover 181
Lawrence 181
Beijing 163
Lauterbourg 152
Seoul 149
Abidjan 145
Catania 136
Los Angeles 121
San Mateo 113
Wilmington 94
Ho Chi Minh City 91
Des Moines 76
Nanchang 73
Civitanova Marche 70
Hanoi 63
Houston 63
Hebei 62
Saint Petersburg 59
Council Bluffs 57
New York 55
Changsha 49
Shenyang 49
São Paulo 49
Jiaxing 42
Lagos 42
Ottawa 42
Abuja 41
Bremen 41
Dakar 35
Munich 31
Seattle 31
The Dalles 29
Buffalo 27
Tianjin 27
Columbus 25
Rio de Janeiro 24
Warsaw 23
Grafing 22
Orem 22
Brooklyn 21
London 20
Helsinki 19
Montreal 19
Mumbai 19
Leawood 18
San Francisco 18
Atlanta 17
Da Nang 17
Pune 17
Hong Kong 16
Johannesburg 16
Norwalk 16
Tokyo 16
Poplar 15
Ann Arbor 14
Chennai 14
Haiphong 14
Boston 13
Kunming 13
Washington 13
Amsterdam 12
Augusta 12
Belo Horizonte 12
Brussels 12
Phoenix 12
Tashkent 12
Denver 11
Falls Church 11
Goiânia 11
Milan 11
Rome 11
Ardabil 10
Brasília 10
Charlotte 10
Guangzhou 10
Redondo Beach 10
Stockholm 10
Ankara 9
Cotonou 9
Dong Ket 9
Frankfurt am Main 9
Hangzhou 9
Jinan 9
Liberty Lake 9
Mexico City 9
Totale 11.363
Nome #
N-acetylcysteine causes analgesia by activating group II metabotropic glutamate receptors 324
A dual mechanism of neuroprotection by transforming growth factor-β1 against β-amyloid neurotoxicity 198
A major role for astrocytes in the neuroprotective effect of estrogen 173
A New Ratiometric Lysosomal Copper(II) Fluorescent Probe To Map a Dynamic Metallome in Live Cells 163
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 160
Neurobiological links between depression and AD: the role of TGF-β1 signaling as a new pharmacological target 157
Increased heat pain tolerance but hyperalgesia to tonic inflammatory pain in the CRND8 mouse model of Alzheimer’s disease 156
A NANOPLATFORM BASED ON SILICA CORE-SHELL NANOPARTICLES AND CHEMOSENSORS FOR MONITORING INTRACELLULAR DYNAMICS OF COPPER TRAFFICKING 155
Ac-LPFFD-Th: A Trehalose-Conjugated Peptidomimetic as a Strong Suppressor of Amyloid- Oligomer Formation and Cytotoxicity 154
Beta-amyloid monomers are neuroprotective 153
Acrivation of cell cycle-associated proteins in neuronal death: a mandatory or dispensable path? 150
A dual mechanism of neuroprotection by transforming growth factor-β1 against β-amyloid neurotoxicity 148
Acetyl-L-carnitine in neuropathic pain: experimental data 144
Erratic expression of DNA polymerases by beta-amyloid causes neuronal death 143
Metabotropic glutamate receptors in glial cells: A New Potential Target for Neuroprotection? 143
Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide. 142
A new function for ß-amyloid monomers 141
Abeta(25-35) and its C- and/or N-blocked derivatives: Copper driven structural features and neurotoxicity 140
Alzheimer's disease: brain expression of a metabolic disorder? 139
Alzheimer's disease research enters a "new cycle": how significant? 138
Activation of metabotropic glutamate receptors prevents neuronal apoptosis in culture 138
A role for estrogen in early differentiation: characterization in neurospheres 137
A ratiometric naphthalimide sensor for live cell imaging of copper(I) 137
β-amyloid-activated cell cycle in SH-SY5Y neuroblastoma cells: Correlation with the MAP kinase pathway 137
Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration 132
Anabolic-androgenic steroid effects on cultured cortical neurons 130
Beta-Amyloid Monomer and Insulin/IGF-1 Signaling in Alzheimer's Disease 126
Hyperalgesic activity of kisspeptin in mice 124
Activation of group III metabotropic glutamate receptors is neuroprotective in cortical cultures 123
Activation of metabotropic glutamate receptors coupled to inositol phospholipid hydrolysis amplifies NMDA-induced neuronal degeneration in cultured cortical cells 123
Molecular connections between DNA replication and cell death in beta-amyloid-treated neurons 123
Neuroprotective effects of the monoamine oxidase inhibitor tranylcypromine and its amide derivatives against Aβ(1-42)-induced toxicity 113
A novel rat gene encoding a Humanin-like peptide endowed with broad neuroprotective activity 113
Red-Light-Photosensitized Tyrosine 10 Nitration of β-Amyloid1-42 Diverts the Protein from Forming Toxic Aggregates. 112
L-acetylcarnitine: a proposed therapeutic agent for painful peripheral neuropathies 112
A promising connection between BDNF and Alzheimer's disease 108
Fluoxetine prevents Aβ1-42-induced toxicity via a paracrine signaling mediated by transforming-growth-factor-β1 108
Alzheimer's disease 107
Amyloid Beta monomers regulate cyclic adenosine monophosphate response element binding protein functions by activating type-1 insulin-like growth factor receptors in neuronal cells 103
Novel neuronal targets for the acetylcholinesterase inhibitor donepezil 101
The monomer state of beta-amyloid: where the Alzheimer's disease protein meets physiology 99
Effect of nitric oxide synthase induction on the expression of mitochondrial respiratory chain enzyme subunits in mixed cortical and astroglial cell cultures 99
Biomolecule And Cell Interactions Studied By Surface Plasmon Resonance Imaging 97
Differentiating effects of ß-amyloid on neural progenitors cells 97
The nature of the cell cycle in neurons: Focus on a "non-canonical" pathway of DNA replication causally related to death 97
Beta-amyloid increases neuronal susceptibility to injury by glucose deprivation 96
Ataxia telangiectasia: drug repositioning for pediatric treatment of a rare genetic neurological disease 95
Astrocyte-like cells as a main target for estrogen action during neuronal differentiation 95
Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons 95
Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic? 94
Metabotropic receptors as target for drugs of potential use in the treatment of neuropathic pain 94
β-Amyloid neurotoxicity: A discussion of in vitro findings 93
PHARMACOLOGICAL EVALUATION OF POTENT SIGMA LIGANDS IN β-AMYLOID INDUCED NEURODEGENERATION 93
The cell cycle molecules behind neurodegeneration in Alzheimer's disease: perspectives for drug development 92
Changes of ERalfa expression in astrocytes affect ß-amyloid-induced neuronal death 92
β-amyloid monomers drive up neuronal aerobic glycolysis in response to energy stressors 92
From cell cycle activation to inhibition of the Wnt pathway: a linking bridge between beta-amyloid and neruodegenration in Alzheimer's disease 91
Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity 91
Group-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotection 90
TGF-beta 1 targets GSK-3 beta/beta-catenin pathway via ERK activation: role in the transition of human lung fibroblasts into myofibroblasts 90
TGF-ß1 protects against Aß-neurotoxicity via the phosphatidylinositol-3-kinase pathway 90
The mGlu5 receptor: a key regulator of neuronal selection? 89
L-acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors 89
Effect of no synthase induction in astroglial and neuronal cell cultures on the expression of mitochondrial respiratory chain enzyme subunits 88
mGlu2 metabotropic glutamate receptors restrain inflammatory pain and mediate the analgesic activity of dual mGlu2/mGlu3 receptor agonists 88
Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine 88
Metabotropic glutamate receptors as targets for neuroprotective drugs 87
DNA polymerase-beta is expressed early in neurons of Alzheimer's disease brain and is loaded into DNA replication forks in neurons challenged with beta-amyloid 87
Epigenetic control of chronic pain mechanism 87
Neurotoxic properties of the anabolic androgenic steroids nandrolone and methandrostenolone in primary neuronal cultures 87
Progenitor cells from the adult mouse brain acquire a neuronal phenotype in response to beta-amyloid 87
Expression and coupling to polyphosphoinositide hydrolysis of group I metabotropic glutamate receptors in early postnatal and adult rat brain 86
The mGluR2 Activation Machinery and Treatment of Chronic Pain: from L-acetyl Carnitine to N-Acetyl Cysteine 86
Better outcomes for everybody evaluates the effectiveness and cost-effectiveness of a pharmacist-led intervention, delivered by community pharmacists in collaboration with physicians, in improving disease control, compared with usual care, in asthma and COPD patients during and after COVID-19 85
The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression 85
An enhanced expression of the immediate early gene, Egr-1, is associated with neuronal apoptosis in culture 84
L-Acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors 84
Mitotic signaling by beta-amyloid causes neuronal death 84
The Wnt antagonist, Dickkopf-1, as a target for the treatment of neurodegenerative disorders 84
Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? 84
Repeated injections of piracetam improve spatial learning and increase the stimulation of inositol phospholipid hydrolysis by excitatory amino acids in aged rats 84
DIFFERENTIATING EFFECTS OF B-AMYLOID IN CULTURED NEUROSPHERES 84
Depression and Alzheimer's disease: neurobiological links and common pharmacological targets 84
Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncology 83
Specific binding sites for inositolhexakisphosphate in brain and anterior pituitary 83
Multiple transducing pathways participate to the induction of a mitotic cell cycle by b-amyloid peptide in differentiated neuroblastoma cells 83
Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against beta-amyloid toxicity 83
Glia mediates the neuroprotective action of estradiol on {beta}-amyloid-induced neuronal death 83
Metabotropic glutamate receptor agonists stimulate polyphosphoinositide hydrolysis in primary cultures of rat hepatocytes 82
Targeting chronic pain with epigenetic drugs: Focus on mGlu2 receptors 81
An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors 81
Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain 81
The Wnt pathway, cell-cycle activation and beta-amyloid: novel therapeutic strategies in Alzheimer's disease? 81
Metabotropic glutamate receptors and neurodegeneration 80
Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia 80
Protective action of idebenone against excitotoxic degeneration in cultured cortical neurons 79
Nootropic drugs positively modulate alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-sensitive glutamate receptors in neuronal cultures 79
Metabotropic glutamate receptor subtypes influence neuronal degeneration through different mechanisms 79
Evidence for an activity-dependent switch in the regulation of excitotoxic neurodegeneration by group-I mGlu receptors 79
TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts 79
Totale 10.867
Categoria #
all - tutte 56.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.771


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021284 0 0 0 0 0 0 0 0 0 0 236 48
2021/20221.320 179 184 2 21 208 8 191 39 121 7 62 298
2022/20232.291 194 61 20 203 222 397 6 549 534 13 68 24
2023/2024798 53 106 31 60 43 140 39 72 3 28 145 78
2024/20253.393 32 532 196 140 730 404 95 160 250 324 237 293
2025/20266.791 462 406 1.386 362 1.123 1.296 886 159 379 327 5 0
Totale 17.064